Darvon, Darvocet Recall Issued Due to Risk of Potentially Fatal Heart Rhythm Abnormalities

October 14, 2013

Important Information

ClassAction.org is no longer reviewing claims for this case. The information here is for reference only. Up-to-date information and resources can be found here.

Comments |

At A Glance

This Alert Affects
Patients who have been prescribed Darvon, Darvocet, or generic propoxyphene-containing products.
Damages
Studies indicate that propoxyphene, even when taken at the recommended dosage, can increase the risk of abnormal heart rhythms, which have been linked to serious negative effects, including death. Past issues that have been linked to these medications include accidental overdose, suicide, nausea, and vomiting.
Company(ies)
Xanodyne Pharmaceuticals and the generic manufacturers of propoxyphene-containing products.
Additional Details
Darvon and Darvocet are brand names for propoxyphene, a prescription pain medication used to relieve mild to moderate pain.
Date
The Darvocet and Darvon recall was issued on November 19, 2010.